Cancer diagnosis and treatment may improve with liquid biopsy
10/02/2013
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood - and it can support the cells' growth for further analysis. The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide...
Cancer therapies likely to improve with new insights into DNA repair process
10/02/2013
By detailing a process required for repairing DNA breakage, scientists at the Duke Cancer Institute have gained a better understanding of how cells deal with the barrage of damage that can contribute to cancer and other diseases. The insights, reported online the week of Sept...
Urgent need to tackle disparities in cancer care worldwide the focus of new report
10/02/2013
A proposal for a new financing model to tackle the major disparities that exist in the prevention, diagnosis, treatment and outcome of cancer in countries worldwide has been presented at the 2013 European Cancer Congress (ECCO 2013)...
First pre-surgery breast cancer drug approved by FDA
10/02/2013
The US Food and Drug Administration (FDA) has approved the first drug to be used in early stage breast cancer treatment. Perjeta (pertuzumab) will be used as part of a complete treatment regimen for patients before surgery (neoadjuvant setting)...
Compound developed that may treat erectile dysfunction priapism
10/02/2013
It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis...
Dealing with side-effects of hormone therapy for prostate cancer
10/02/2013
Flushed face, sweating, a sudden rush of heat. The hot flash, the bane of menopausal women, also can affect men who are undergoing hormone therapy for prostate cancer. But unlike in women, neither soy protein nor a common antidepressant provides relief for men, according to researchers at Wake Forest Baptist Medical Center...
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results presented at the 2013 European Cancer Congress (ECC2013) [1]...
Aspirin may act on two different pathways to improve survival in colon cancer
10/02/2013
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard. Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown...
The biggest killer of Hispanic Texans is cancer
10/02/2013
More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group. The report documents cancer as the leading cause of death among Hispanic Texans under the age of 76. Only three percent of Hispanic Texans are older than 75. Texas's Hispanic population has more than doubled since 1990...
Anti-cancer drug and radiotherapy may lead to treatment for brain tumor
10/02/2013
Results from a clinical trial of a new treatment for glioblastoma suggest that researchers may have found a new approach to treating this most aggressive of brain tumours, as well as a potential new biological marker than can predict the tumour's response to treatment...